Glioz 20 Capsule
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Glioz 20 Capsule contains temozolomide, an alkylating cytotoxic (chemotherapy) medicine. Its labelling describes it for the treatment of brain tumours when they recur or worsen after initial treatment, and for cancer of the brain. It is described as entering the brain tissue and damaging the genetic material of cancer cells so that their growth and multiplication stop. It should be taken as instructed by the doctor and on an empty stomach; the dose, interval, and duration can change depending on the disease and its progress. Results may take weeks or even months to be visible.
Product Information
The following description reflects information associated with temozolomide and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of brain tumours, particularly when they recur or worsen after initial treatment
- Described for cancer of the brain — killing or stopping the growth of cancer cells
- Described as entering brain tissue and damaging the genetic material of cancer cells so growth and multiplication stop
Described Dosage & Administration
- Taken by mouth on an empty stomach, following the doctor’s prescribed duration, interval, and dosage
- The dose, interval, and duration can change depending on the disease and its progress
- Results may take weeks or even months to become visible; alcohol should be avoided and hydration with water maintained
Described Side Effects
Commonly described side effects include:
- Nausea and vomiting
- Constipation and diarrhoea
- Dizziness
- Fever
- Headache
- Fatigue and weakness (including weakness on one side of the body)
- Viral infection
- Hair loss
- Insomnia and loss of appetite
These are described as commonly temporary. The doctor should be informed if they bother the patient, and any severe or persistent reaction requires prompt medical attention.
Precautions
- A complete medical history, including current medications, should be shared with the doctor
- It is described as not for use if pregnant, breastfeeding, or planning a pregnancy
- Alcohol should not be consumed during treatment; staying hydrated with water is advised
- Patience is advised, as results can take weeks or months to appear
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains temozolomide and is used for brain tumours that recur or worsen after initial treatment and for cancer of the brain. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as taken by mouth on an empty stomach, following the doctor’s prescribed duration, interval, and dosage, which can change with the disease’s progress.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.